Deverra Therapeutics, Inc. — Form D
Deverra Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-18. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-18
- Form: D
- Accession: 0001822782-23-000003
- Industry: Biotechnology
- Exemptions: 06b, 3C, 3C.1
- Total offering: $2.4M
- Amount sold: $2.4M
- Minimum investment: $2.4M
- Investors: 1
- Date of first sale: 2023-09-08
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-492316
Issuer
- Name: Deverra Therapeutics, Inc.
- CIK: 0001822782
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1600 FAIRVIEW AVENUE EAST, SEATTLE, WA, 98102
- Phone: 2144788208
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Colleen Delaney | Executive Officer | Wexford, PA |
| Michael Yurkowsky | Executive Officer | Seattle, WA |
| Colleen W Delaney | Executive Officer | Seattle, WA |
| Michael W Yurkowsky | Director | Seattle, WA |
| Michael W Yurkowsky | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More